Browse 1,513 myasthenia gravis clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.
Myasthenia gravis causes muscle weakness that gets worse with use and improves with rest, often starting with a drooping eyelid or double vision. For decades treatment relied mainly on steroids and broad immune suppression, with side effects that can be hard to live with. In recent years several new targeted medicines have been approved that act directly on the antibodies behind the disease.
Location: Silver Spring MD, Detroit MI, Houston TX, Dallas TX
Sponsor: Bio-Path Holdings, Inc.
Sex: All
Age: 18+
Code: NCT04196257
Phase 1, Recruiting
A First-in-human (FIH), Phase I Study of PTX-912 in Patients with Locally Advanced/Metastatic Solid Tumors
for
Advanced Cancer, Solid Tumor, Metastatic Cancer
Location: Miami FL, Omaha NE, Duarte CA
Sponsor: Proviva Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06190886
Phase 1, Recruiting
Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers
for
Metastatic Colorectal Carcinoma,
Location: The Bronx NY, New York NY, Pittsburgh PA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05803382
Phase 1, Recruiting
Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors
for
Anatomic Stage IV Breast Cancer AJCC v8,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT04771520
Phase 2, Recruiting
AnovaOS Network Powered Patient Registry
for
Infectious Disease, Neoplasms,
Location: Arlington Heights IL
Sponsor: Anova Enterprises, Inc
Sex: All
Age: 18+
Code: NCT05013944
Recruiting
Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors
for
Anatomic Stage III Breast Cancer AJCC v8,
Location: Boston MA, Pittsburgh PA, Houston TX, Newport Beach CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 12+
Code: NCT05372640
Phase 1, Recruiting
Trial of DFP-14927 in Advanced Solid Tumors
for
Solid Tumor, Cancer
Location: Houston TX, Los Angeles CA
Sponsor: Delta-Fly Pharma, Inc.
Sex: All
Age: 18+
Code: NCT03943004
Phase 1, Recruiting
Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors
for
Rectal Adenocarcinoma, Clinical Stage: Stage II (T3-4, N-),
Location: Hartford CT, Commack NY, Uniondale NY, Harrison NY,
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All
Age: 18+
Code: NCT04165772
Phase 2, Recruiting
The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing
for
Patients Undergoing Routine Health Care, Heart Diseases,
Location: Chicago IL
Sponsor: University of Chicago
Sex: All
Age: 18+
Code: NCT01280825
Recruiting
Provider-Mediated Communication of Genetic Testing Results to At-Risk Relatives of Cancer Patients to Improve Genetic Counseling and Testing Rates, Family HOPE Study
for
Hematopoietic and Lymphoid System Neoplasm,
Location: Duarte CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT05772130
Recruiting
MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors
for
Solid Tumor, Advanced Cancer, Metastatic Cancer,
Location: Tampa FL
Sponsor: Memgen, Inc.
Sex: All
Age: 18+
Code: NCT05076760
Phase 1, Recruiting
Natural History and Biospecimen Acquisition for Children and Adults With Rare Solid Tumors
for
Malignant Solid Tumors, Other Neoplasms Solid Tumors,